Literature DB >> 35597580

Leveraging Surveillance and Evidence: Preventing Adverse Childhood Experiences Through Data to Action.

Angie S Guinn1, Phyllis G Ottley2, Kayla N Anderson2, Maureen L Oginga2, Derrick W Gervin3, Gayle M Holmes2.   

Abstract

Adverse childhood experiences are potentially traumatic events that occur in childhood that have been associated with lifelong chronic health problems, mental illness, substance misuse, and decreased life opportunities. Therefore, preventing adverse childhood experiences is critical to improving health and socioeconomic outcomes throughout the lifespan. The Preventing Adverse Childhood Experiences: Data to Action (CDC-RFA-CE20-2006) funding initiative is a comprehensive public health approach to adverse childhood experience prevention that aims to understand the prevalence of and risk factors for adverse childhood experiences among youth, track changes in adverse childhood experience prevalence over time, focus prevention strategies, and ultimately measure the success of those evidence-based prevention strategies. Recipients will achieve the goals of the initiative by leveraging multisector partnerships and resources to: (1) enhance and build infrastructure for state-level data collection, analysis, and application of adverse childhood experiences related surveillance data; (2) implement at least 2 prevention strategies based on the best available evidence to prevent adverse childhood experiences; and (3) undertake data to action activities to leverage statewide surveillance data to inform and tailor adverse childhood experience prevention activities. Since the start of this initiative, recipients have focused on building surveillance capacity based on the needs of their individual states; implementing strategies and approaches based on the best available evidence to better prevent adverse childhood experiences; and ultimately improve the mental, physical, and social well-being of their populations. Although evaluation of Preventing Adverse Childhood Experiences: Data to Action is ongoing, this article outlines the current recipient surveillance, prevention, and data-to-action implementation efforts. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2022        PMID: 35597580      PMCID: PMC9210212          DOI: 10.1016/j.amepre.2021.12.003

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   6.604


  17 in total

1.  Essentials for Childhood: Planting the Seeds for a Public Health Approach to Preventing Child Maltreatment.

Authors:  Joanne Klevens; Sandra Alexander
Journal:  Int J Child Maltreat       Date:  2019-01-04

2.  The lifelong effects of early childhood adversity and toxic stress.

Authors:  Jack P Shonkoff; Andrew S Garner
Journal:  Pediatrics       Date:  2011-12-26       Impact factor: 7.124

3.  Prevalence of Childhood Exposure to Violence, Crime, and Abuse: Results From the National Survey of Children's Exposure to Violence.

Authors:  David Finkelhor; Heather A Turner; Anne Shattuck; Sherry L Hamby
Journal:  JAMA Pediatr       Date:  2015-08       Impact factor: 16.193

4.  A Systematic Review of Risk Factors for Intimate Partner Violence.

Authors:  Deborah M Capaldi; Naomi B Knoble; Joann Wu Shortt; Hyoun K Kim
Journal:  Partner Abuse       Date:  2012-04

Review 5.  Preventing Adverse Childhood Experiences: The Role of Etiological, Evaluation, and Implementation Research.

Authors:  Jennifer L Matjasko; Jeffrey H Herbst; Lianne Fuino Estefan
Journal:  Am J Prev Med       Date:  2022-06       Impact factor: 6.604

6.  Technical Packages in Injury and Violence Prevention to Move Evidence Into Practice: Systematic Reviews and Beyond.

Authors:  Tamara M Haegerich; Corinne David-Ferdon; Rita K Noonan; Brian J Manns; Holly C Billie
Journal:  Eval Rev       Date:  2016-09-20

7.  Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study.

Authors:  V J Felitti; R F Anda; D Nordenberg; D F Williamson; A M Spitz; V Edwards; M P Koss; J S Marks
Journal:  Am J Prev Med       Date:  1998-05       Impact factor: 5.043

8.  Vital Signs: Estimated Proportion of Adult Health Problems Attributable to Adverse Childhood Experiences and Implications for Prevention - 25 States, 2015-2017.

Authors:  Melissa T Merrick; Derek C Ford; Katie A Ports; Angie S Guinn; Jieru Chen; Joanne Klevens; Marilyn Metzler; Christopher M Jones; Thomas R Simon; Valerie M Daniel; Phyllis Ottley; James A Mercy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-08       Impact factor: 17.586

9.  Building Infrastructure for Surveillance of Adverse and Positive Childhood Experiences: Integrated, Multimethod Approaches to Generate Data for Prevention Action.

Authors:  Kayla N Anderson; Elizabeth A Swedo; Heather B Clayton; Phyllis Holditch Niolon; Daniel Shelby; Kathleen McDavid Harrison
Journal:  Am J Prev Med       Date:  2022-06       Impact factor: 6.604

Review 10.  Overview and Methods for the Youth Risk Behavior Surveillance System - United States, 2019.

Authors:  J Michael Underwood; Nancy Brener; Jemekia Thornton; William A Harris; Leah N Bryan; Shari L Shanklin; Nicholas Deputy; Alice M Roberts; Barbara Queen; David Chyen; Lisa Whittle; Connie Lim; Yoshimi Yamakawa; Michelle Leon-Nguyen; Greta Kilmer; Jennifer Smith-Grant; Zewditu Demissie; Sherry Everett Jones; Heather Clayton; Patricia Dittus
Journal:  MMWR Suppl       Date:  2020-08-21
View more
  2 in total

Review 1.  Preventing Adverse Childhood Experiences: The Role of Etiological, Evaluation, and Implementation Research.

Authors:  Jennifer L Matjasko; Jeffrey H Herbst; Lianne Fuino Estefan
Journal:  Am J Prev Med       Date:  2022-06       Impact factor: 6.604

2.  Building Infrastructure for Surveillance of Adverse and Positive Childhood Experiences: Integrated, Multimethod Approaches to Generate Data for Prevention Action.

Authors:  Kayla N Anderson; Elizabeth A Swedo; Heather B Clayton; Phyllis Holditch Niolon; Daniel Shelby; Kathleen McDavid Harrison
Journal:  Am J Prev Med       Date:  2022-06       Impact factor: 6.604

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.